Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.03
Delayed Data
As of Dec 08
 +0.10 / +3.41%
Today’s Change
2.20
Today|||52-Week Range
4.07
-14.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.1M3.6M5.5M6.8M
 
 
 
 
 
Cost of Goods Sold2.3M0.000.00--
 
 
Depreciation And Amortization2.9M3.4M4.0M4.1M
 
 
 
 
 
 
Operating ExpensesGross Income-1.2M185.0K1.5M--
 
 
 
 
General Expenses80.3M122.6M131.0M130.7M
 
 
 
 
 
Research And Development65.5M102.0M100.2M102.0M
 
 
 
 
 
Total Operating Expenses85.6M126.0M135.0M134.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-81.4M-122.4M-129.5M-128.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-5.0M
 
 
Interest Expense On Debt927.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-81.6M-118.1M-127.2M-128.5M
 
 
 
 
 
Net Income-81.6M-118.1M-127.2M-128.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS79.8M89.4M97.1M101.5M
 
 
 
 
 
Shares To Calculate EPS Diluted79.8M89.4M97.1M101.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$1.32-$1.31-$1.27
 
 
 
 
 
EPS Diluted-$1.02-$1.32-$1.31-$1.27